Post by
Kingofstockst on Apr 28, 2021 7:10am
This
Is big, so canada market with redevu go read previous NR so money will start coming in 4th quarter I believe, phase2 trial in USA and now Europe did I say wow wow. Man oh man glta we on fire...
Comment by
Davesnothere on Apr 28, 2021 7:31am
I like this line from today's news release : We are seeking guidance from the Malta Medicines Authority on Tetra's clinical development program of REBORN2 as we plan for global commercialization of QIXLEEF," said Guy Chamberland, CEO and CRO of Tetra Bio-Pharma Inc WOW
Comment by
JACKTHEBEAR2 on Apr 28, 2021 8:15am
The wording is very encouraging and shows the level on which Tetra is thinking. It will not be long before those revenue streams get factored into the price and thats when the real fun starts. Things are moving in the right direction.
Comment by
Kingofstockst on Apr 28, 2021 8:59am
1 more thing I forgot to mention the partnership they have with George Mason University for the ards study..... nih lab remember that and who there working with and I'm not making this stuff up it's all in past NR and ards will be global for covid short term and which Is bigger long term sepsis.. glta go tbp